Frequency of Prescription Claims for Drugs that May Interact with Janus Kinase Inhibitors Among Patients with Rheumatoid Arthritis in the US
Author:
Funder
Eli Lilly and Company
Incyte Corporation
Publisher
Springer Science and Business Media LLC
Link
http://link.springer.com/content/pdf/10.1007/s40744-020-00275-8.pdf
Reference15 articles.
1. Kvien TK. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics. 2004;22:1–12.
2. Treharne GJ, Douglas KM, Iwaszko J, et al. Polypharmacy among people with rheumatoid arthritis: the role of age, disease duration and comorbidity. Musculoskelet Care. 2007;5:175–90.
3. Hines LE, Murphy JE, Grizzle AJ, Malone DC. Critical issues associated with drug–drug interactions: highlights of a multistakeholder conference. Am J Health Syst Pharm. 2011;68:941–6.
4. Fleischmann R, Schiff M, van der Heijde D, et al. Baricitinib, methotrexate, or combination in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment. Arthritis Rheumatol. 2017;69:506–17.
5. Lee EB, Fleischmann R, Hall S, et al. Tofacitinib versus methotrexate in rheumatoid arthritis. N Engl J Med. 2014;370:2377–86.
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Prevalence and Appropriateness of Polypharmacy in Older Adults with Inflammatory Bowel Diseases;Digestive Diseases and Sciences;2024-01-25
2. Drug-drug interactions between COVID-19 drug therapies and antidepressants;Expert Opinion on Drug Metabolism & Toxicology;2023-11-30
3. Development and validation of a multiplex HPLC-MS/MS assay for the monitoring of JAK inhibitors in patient plasma;Journal of Chromatography B;2023-11
4. Suboptimal management of rheumatoid arthritis in France: a real-world study based on data from the French National Health Data System;RMD Open;2023-10
5. JAK-STAT pathway inhibitors in dermatology;Anais Brasileiros de Dermatologia;2023-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3